Ephylone

1. 2026-10-19issueIssued info_card
2. 2026-09-07srcAnalytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone).
3. 2026-09-07srcNeuropharmacology of Synthetic Cathinones
4. 2026-09-07srcDesigner drugs: mechanism of action and adverse effects
5. 2026-09-07srcThe hydrochloride hydrates of pentylone and dibutylone and the hydrochloride salt of ephylone: the structures of three novel designer cathinones
6. 2026-09-07srcFatal intoxication with N-ethylpentylone: a case report and method for determining N-ethylpentylone in biological material
7. 2026-09-07srcDrug-related deaths at Australian music festivals
8. 2026-09-07srcLethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA.
9. 2026-09-07srcStructure-Activity Relationship of Synthetic Cathinones: An Updated Review
10. 2026-09-07srcThe abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
11. 2026-09-07srcAcute toxicity from the synthetic cathinone N-ethylpentylone (ephylone) in the United Kingdom.
12. 2026-09-07srcMethod Validation of Seven Synthetic Cathinones by LC-MS/MS Analysis and the Prevalence of N-Ethylpentylone in Postmortem Casework.
13. 2026-09-07srcReports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
14. 2026-09-07srcToxicological evaluation, postmortem case descriptions, and pharmacological activity of N,N-dimethylpentylone and related analogs
15. 2026-09-07srcUnderstanding the pharmacokinetics of synthetic cathinones: Evaluation of the blood-brain barrier permeability of 13 related compounds in rats.
16. 2026-09-07srcSex differences in the effects of N-ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression.
17. 2026-09-07srcPharmacological characterization of designer cathinones in vitro
18. 2026-09-07srcBehavioural and neurochemical effects after repeated administration of N-ethylpentylone (ephylone) in mice.
19. 2026-09-07srcMetabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems
20. 2026-09-07srcSynthetic Cathinones and Neurotoxicity Risks: A Systematic Review
21. 2026-09-07srcComparative Assessment of the Addictive Potential of Synthetic Cathinones by Zebrafish Conditioned Place Preference (CPP) Paradigm
22. 2026-09-07srcIn vitro metabolic profiling of methylenedioxy-substituted synthetic cathinones for enhanced detection in urine sample analysis
23. 2026-09-07srcNovel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
24. 2026-09-07srcPlacement of N-Ethylpentylone in Schedule I (Permanent)
25. 2026-09-07srcN-Ethylnorpentylone - ECDD Repository
26. 2026-09-07srcTemporary Placement of N-Ethylpentylone in Schedule I
27. 2026-09-07srcWeekly Dose: ephylone, the dangerous designer stimulant found at Groovin the Moo
28. 2026-09-04issueIssued emergency
29. 2026-09-04issueIssued info_card
30. 2026-09-04issueIssued notice
31. 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
32. 2026-06-04publicationPublication — backfill
33. 2026-05-11revisionRevision 1
34. 2026-05-11absenceSearched ClinicalTrials.gov for "ephylone N-ethylpentylone cathinone" — no results
35. 2026-05-11absenceSearched PubMed for "ephylone bk-EBDP cathinone pharmacology" — no results
36. 2026-05-11genGeneration — pipeline-v5 · with 2 morepipeline-v5
37. 2026-05-11rungeneration run

The same entries, as forms: six forms.